Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biosensors, Biomarkers & Diagnostics

Harshini Mukundan's Biography

Harshini Mukundan, Principal Investigator, Los Alamos National Laboratory

Dr Harshini Mukundan has a MS degree in microbiology, and a Ph. D in Biomedical Sciences. She worked for two years as a Team Leader in a start up biotechnologycompany and was instrumental in leading efforts for the development of sensors for detection of bio-warfare agents. Subsequently, she joined the Los Alamos National Laboratory, a US Federal Department of Energy laboratory, as a NIH Post-doctoral fellow to develop diagnostics for active tuberculosis. After two years, she was converted as a staff scientist. Today, she is a scientist four (equivalent of full professor), and leads an extremely multidisciplinary team for the development of diagnostic solutions for infectious diseases. She has authored over 50 peer-reviewed manuscripts, written several book chapters, authored books, and has five patents to her credit. She is the winner of several awards such as the New Mexico Technology Council’s Women in Technology Award in 2016, and the Los Alamos National Laboratory’s Fellow’s Prize in 2017. Her dream is to develop effective, inexpensive, technically simple point of care diagnostics for universal application towards all infectious disease.

Harshini Mukundan Image

Rapid Pathogen-Biomarker Based Universal Diagnostics of Bacterial Infection at the Point of Care

Friday, 26 May 2017 at 10:35

Add to Calendar ▼2017-05-26 10:35:002017-05-26 11:35:00Europe/LondonRapid Pathogen-Biomarker Based Universal Diagnostics of Bacterial Infection at the Point of CareBiosensors, Biomarkers and Diagnostics in

The talk will highlight how they have developed a suite of patented methods for the rapid detection of pathogen signatures, and will discuss its feasibility of application in diagnosis of infection associated with gram-positive, negative and indeterminate pathogens in blinded clinical samples for which the presenter used novel sensor technology developed at the Los Alamos National Laboratory.It will then show how their technologies are now on the verge of market development, and how transition plans are being developed and executed to ensure commercial transition.

Add to Calendar ▼2017-05-25 00:00:002017-05-26 00:00:00Europe/LondonBiosensors, Biomarkers and DiagnosticsBiosensors, Biomarkers and Diagnostics in